Canadian health tech founders do not struggle with ambition, but often find difficulty choosing where to expand. While the U.S. may seem like the obvious choice, it often delivers fragmented buyers, long sales cycles and tricky regulatory hurdles. The U.K. offers a different path: A single national health system, increasing demand for digital solutions and procurement models that reward measurable value.

Join MaRS and Export Development Canada for a session designed for founders eyeing the U.K. as a viable expansion market. You will hear directly from Canadian founders who have scaled into the U.K., partnered with the NHS and navigated procurement, regulation and early traction. A U.K. market entry expert will also provide technical insight into regulatory pathways and procurement structures.

Who should attend?

Canadian health tech and digital health startup founders, CEOs and senior leaders, investors, ecosystem partners and commercialization advisors.